First-line monotherapy with nivolumab (NIVO; anti-programmed death-1 [PD-1]) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy and correlation of outcomes with PD-1 ligand (PD-L1) expression.

被引：0
|
作者：
Gettinger, Scott N.
Hellmann, Matthew David
Shepherd, Frances A.
Antonia, Scott Joseph
Brahmer, Julie R.
Chow, Laura Quan Man
Goldman, Jonathan Wade
Juergens, Rosalyn A.
Borghaei, Hossein
Ready, Neal
Gerber, David E.
Nathan, Faith Ellen
Shen, Yun
Harbison, Christopher
Rizvi, Naiyer A.
机构：
[1] Yale Canc Ctr, New Haven, CT USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[5] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[6] Univ Washington, Seattle, WA 98195 USA
[7] Univ Calif Los Angeles, Los Angeles, CA USA
[8] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[9] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[10] Duke Univ, Med Ctr, Durham, NC USA
[11] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[12] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8025
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of First-Line Nivolumab (NIVO; Anti-Programmed Death-1 [PD-1]) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC)
    Rizvi, Naiyer A.
    Gettinger, Scott N.
    Goldman, Jonathan W.
    Hellmann, Matthew D.
    Chow, Laura Q.
    Juergens, Rosalyn
    Borghaei, Hossein
    Brahmer, Julie R.
    Shen, Yun
    Harbison, Christopher
    Nathan, Faith
    Ready, Neal
    Antonia, Scott J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S176 - S176
  • [2] Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
    Liang, Jiaqi
    Li, Ming
    Sui, Qihai
    Hu, Zhengyang
    Bian, Yunyi
    Huang, Yiwei
    Zhan, Cheng
    Jiang, Wei
    Wang, Qun
    Tan, Lijie
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1302 - +
  • [3] Efficacy and safety of the PD-1/PD-L1 in metastasic non-small cell lung cancer (NSCLC)
    Gonzalez-Velez, Abel
    Pino-Villareal, Luis E.
    Barrera-Barinas, Alexander
    Castillo-Niuman, Andrea
    Tolosa-Perez, Erica N.
    Castelblanco, Diana, I
    Pinzon-Florez, Carlos E.
    Yomayusa, Nancy
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (03): : 111 - 123
  • [4] Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer
    Jove, Maria
    Vilarino, Noelia
    Nadal, Ernest
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S364 - S368
  • [5] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 475A - 475A
  • [6] Prognostic Impact of Programmed Cell Death-1 (PD-1) and PD-Ligand 1 (PD-L1) Expression in Thymic Cancer
    Funaki, S.
    Shintani, Y.
    Ose, N.
    Kawamura, T.
    Kanzaki, R.
    Minami, M.
    Okumura, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2064 - S2065
  • [7] PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement
    Isla, Dolores
    Sanchez, Alfredo
    Casal, Joaquin
    Cobo, Manuel
    Majem, Margarita
    Reguart, Noemi
    Zugazagoitia, Jon
    Bernabe, Reyes
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [8] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
  • [9] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
  • [10] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    [J]. MODERN PATHOLOGY, 2017, 30 : 475A - 475A
12345